Madura James A, Yum Moo-Nahm, Lehman Glen A, Sherman Stuart, Schmidt C Max
Department of Surgery, The Indiana University Medical Center, Indianapolis, Indiana, USA.
Am Surg. 2004 Feb;70(2):106-12; discussion 113.
Ninety per cent of pancreatic cysts are inflammatory pseudocysts. The other 10 per cent are congenital or neoplastic and include congenital true cysts, retention cysts, lymphoepithelial cysts, the mucinous cystadenoma, mucinous cystadenocarcinoma, and serous microcystic cystadenomas and the more recently described intraductal papillary mucin-secreting neoplasms. The advent of computerized tomographic scanning, endoscopic retrograde cholangiopancreatography (ERCP), and endoscopic ultrasonography (EUS) has brought many of these lesions to light when they are minimally symptomatic or are incidentally found while investigating unrelated problems. If there is any suspicion of actual or potentially malignant disease, then total excision of the lesion with part of or the entire pancreas is indicated to achieve a likely cure, as survival is better than for the more common ductal adenocarcinomas. There are few reliable preoperative studies to distinguish accurately the etiology and prognosis of this spectrum of cystic lesions, and usually the actual diagnosis is made only at the time of operation or histopathologic examination after the cystic lesion has been biopsied or excised. If a cyst is confirmed to be totally benign, as in the congenital true cyst, lymphoepithelial cyst, or a benign mucinous cyst, they may lend themselves to nonoperative observation or excision without sacrifice of pancreatic parenchyma. However, many mucin-producing cystic lesions may evolve into a dysplastic or invasive malignant lesion requiring more aggressive resective treatment, and it is important not to miss that diagnosis early when cure is still possible. This report presents four benign mucin-secreting cysts treated by local excision. All four were in the head of the pancreas and communicated with the main pancreatic duct and lacked ovarian-type stroma, thus categorizing them as side-branch intraductal papillary mucinous neoplasms. These lesions were able to be easily dissected out of the pancreas with only one patient developing a transient pancreatic fistula. Intraoperative and final histopathology confirmed the benign status, and these patients have remained disease free 3 to 5 years postoperatively. A review of benign tumors reported to have been treated by cyst enucleation in the literature confirms the rationale of this approach in highly selected lesions.
90%的胰腺囊肿为炎性假囊肿。另外10%为先天性或肿瘤性,包括先天性真性囊肿、潴留性囊肿、淋巴上皮囊肿、黏液性囊腺瘤、黏液性囊腺癌、浆液性微囊性囊腺瘤以及最近描述的导管内乳头状黏液分泌性肿瘤。计算机断层扫描、内镜逆行胰胆管造影(ERCP)和内镜超声检查(EUS)的出现,使许多这类病变在症状轻微或在检查无关问题时偶然被发现。如果怀疑有实际的或潜在的恶性疾病,那么切除病变组织及部分或整个胰腺以实现可能的治愈是必要的,因为其生存率优于更常见的导管腺癌。目前几乎没有可靠的术前研究能准确区分这类囊性病变的病因和预后,通常只有在对囊性病变进行活检或切除后进行手术或组织病理学检查时才能做出实际诊断。如果囊肿被证实完全良性,如先天性真性囊肿、淋巴上皮囊肿或良性黏液性囊肿,则可进行非手术观察或切除而不损伤胰腺实质。然而,许多产生黏液的囊性病变可能会演变成发育异常或侵袭性恶性病变,需要更积极的切除治疗,因此在仍有可能治愈时尽早做出诊断很重要。本报告介绍了4例经局部切除治疗的良性黏液分泌性囊肿。这4例均位于胰头,与主胰管相通且缺乏卵巢型间质,因此将它们归类为分支型导管内乳头状黏液性肿瘤。这些病变能够很容易地从胰腺中分离出来,只有1例患者出现了短暂的胰瘘。术中及最终组织病理学证实了其良性状态,这些患者术后3至5年无疾病复发。对文献中报道的经囊肿摘除术治疗的良性肿瘤进行回顾,证实了这种方法在高度选择的病变中的合理性。